Literature DB >> 4073869

Pharmacokinetics of cephalosporins in normal and septicemic rabbits.

U Ganzinger, A Haslberger.   

Abstract

The differences in the pharmacokinetics of cefotaxime, moxalactam, and CPW 86-363, a new expanded-spectrum cephalosporin, were studied in healthy rabbits and in rabbits infected intravenously with Streptococcus pneumoniae. The pharmacokinetic analysis of concentration-time courses in the sera of infected animals according to a two compartment-model evidenced a clear decrease of drug fractions in the central compartment but enhanced drug fractions in the peripheral compartment. The shift was more pronounced in animals which received CPW 86-363 (60%; P less than 0.05) than in those which received cefotaxime (20%) or moxalactam (5%). Corresponding increases in drug concentration were observed in soft tissue interstitial fluid; therefore, the areas under the curve and mean residence times in the soft tissue interstitial fluid of infected rabbits were prolonged. The shift of drug fractions from the central compartment to other body fluid compartments during infection was thought to be due to cardiovascular changes associated with fever. No changes in serum binding of the three drugs were found during the course of the infection. The quantitative differences in the extent of altered distribution properties of the drugs might be due to variations in the physicochemical properties of the drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073869      PMCID: PMC180286          DOI: 10.1128/AAC.28.4.473

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  [A simple statistical dosage metabolism law].

Authors:  F H DOST
Journal:  Klin Wochenschr       Date:  1958-07-15

Review 2.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

3.  Renal hemodynamic effects of sepsis.

Authors:  I K Rosenberg
Journal:  Heart Lung       Date:  1976 Sep-Oct       Impact factor: 2.210

4.  Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.

Authors:  J R Perfect; D T Durack
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

Review 5.  Disease-induced modifications of drug pharmacokinetics.

Authors:  J Barre; G Houin; F Brunner; F Bree; J P Tillement
Journal:  Int J Clin Pharmacol Res       Date:  1983

6.  PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation.

Authors:  R Gomeni
Journal:  Comput Biol Med       Date:  1984       Impact factor: 4.589

7.  Effect of intravascular pneumococcal challenge on vascular permeability in rabbits.

Authors:  S E Goldblum; W P Reed
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

8.  Composition of fluids from diffusion chambers implanted in the soft tissue and kidneys of rabbits.

Authors:  F P Schmook; M Nefzger; G Laber; A Georgopoulos; R Czok; E Schütze
Journal:  Infection       Date:  1980       Impact factor: 3.553

9.  A diffusion chamber technique for measuring concentrations of antibiotics in interstitial fluid.

Authors:  G Laber; E Schütze; R Leskova; R Kolb; A Georgopoulos
Journal:  Infection       Date:  1980       Impact factor: 3.553

10.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

  10 in total
  5 in total

1.  Quantification of tissue distribution of antibiotics by kinetic hysteresis analysis.

Authors:  U Ganzinger; K Neumann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Critical importance of in vivo amoxicillin and cefotaxime concentrations for synergy in treatment of experimental Enterococcus faecalis endocarditis.

Authors:  O Join-Lambert; J L Mainardi; C Cuvelier; S Dautrey; R Farinotti; B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 3.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

4.  Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.

Authors:  B Ljungberg; I Nilsson-Ehle
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

Authors:  B A Christensson; I Nilsson-Ehle; B Ljungberg; A Lindblad; A S Malmborg; L Hjelte; B Strandvik
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.